Patent Assignment
Reel/Frame 037406/0473
General Conveyance and Assumption Agreement
Recorded: 2015-12-31
Pages: 5
Assignor
RVX THERAPEUTICS INC.
Executed: 2014-05-01
Assignee
ZENITH EPIGENETICS CORP.
300, 4820 RICHARD ROAD SW, CALGARY, ABT3E6L1, CANADA
Covered Property
(1)
Novel Bicyclic Bromodomain Inhibitors
PCT:
PCT/US2014/043423 ↗
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 21, 2015
From: QUINN, JOHN FREDERICK; DUFFY, BRYAN CORDELL; LIU, SHUANG; WANG, RUIFANG
To: ZENITH EPIGENETICS CORP.
Reel/Frame 037354/0965 →
Assignment of Assignor's Interest
Dec 31, 2015
From: LIU, SHUANG; QUINN, JOHN FREDERICK; DUFFY, BRYAN CORDELL; WANG, RUIFANG
To: RVX THERAPEUTICS INC.
Reel/Frame 037388/0748 →
Change of Name
Dec 21, 2016
From: ZENITH EPIGENETICS CORP.
To: ZENITH CAPITAL CORP.
Reel/Frame 041120/0548 →
Assignment of Assignor's Interest
Dec 23, 2016
From: ZENITH CAPITAL CORP.
To: ZENITH EPIGENETICS LTD.
Reel/Frame 041182/0891 →